ZEFFIX

This brand name is authorized in Australia, Austria, Croatia, Cyprus, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug ZEFFIX contains one active pharmaceutical ingredient (API):

1	Lamivudine UNII 2T8Q726O95 - LAMIVUDINE
	Lamivudine is a nucleoside analogue which has activity against human immunodeficiency virus (HIV) and hepatitis B virus (HBV). Its main mode of action is as a chain terminator of viral reverse transcription.
	Read more about Lamivudine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ZEFFIX Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J05AF05	Lamivudine	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
Discover more medicines within J05AF05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10315X
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00587040, 00587057, 01273875, 01517260, 01529665, 01815827, 02028729, 02031625, 02448199, 02448207, 02683581, 02683598
EE	Ravimiamet	1043042, 1210161, 1215391
ES	Centro de información online de medicamentos de la AEMPS	99114001, 99114003
FI	Lääkealan turvallisuus- ja kehittämiskeskus	051508
FR	Base de données publique des médicaments	63439683, 68427877
GB	Medicines & Healthcare Products Regulatory Agency	139837, 147673, 164497, 375454, 38711
HK	Department of Health Drug Office	64011
IE	Health Products Regulatory Authority	88260
IL	מִשְׂרַד הַבְּרִיאוּת	4207, 4208
IT	Agenzia del Farmaco	034506016
LT	Valstybinė vaistų kontrolės tarnyba	1003227, 1006258, 1006259
NL	Z-Index G-Standaard	14560348
NL	Z-Index G-Standaard, PRK	53783, 56162
NZ	Medicines and Medical Devices Safety Authority	8082, 8302
PL	Rejestru Produktów Leczniczych	100093375, 100093381
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65306001, W65306002
SG	Health Sciences Authority	11152P
TN	Direction de la Pharmacie et du Médicament	5463112H
TR	İlaç ve Tıbbi Cihaz Kurumu	8699522096008